Navigation Links
Senior Regulatory Affairs and Program Management Executive, Robert Peterson, RAC, Joins NDA Partners
Date:11/14/2019

NDA Partners Chairman Carl Peck, MD, announced today that Robert Peterson, RAC, a regulatory affairs and program management executive with more than 33 years of regulatory and product development experience in the biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant.

Robert Peterson has extensive experience in formulating and executing regulatory, clinical, and product development strategies, interfacing with regulatory agencies, and filing regulatory submissions. In addition, he has extensive hands-on experience in research and development, manufacturing, nonclinical and clinical studies, and leading cross-functional teams in both small and large companies.

Most recently, Mr. Peterson was Executive Director of Regulatory Affairs at Liquidia Technologies Inc. He has also served as Vice President of Product Development and Regulatory Affairs at Nephrogenex Inc., Director of Research and Development at Cardiopolymers Inc., and Director of Product Development at Biostratum Inc. In his early career, he served as Director of Research and Development in the Vascular Division at Baxter Healthcare.

“Mr. Peterson’s extensive experience leading cross-functional regulatory and product development teams in both small and large companies will bring great value to our clients who need full support for their product development programs,” said Dr. Peck. “We are pleased to welcome him to NDA Partners.”

Robert Peterson earned his Master of Engineering degree in biomedical engineering from the University of California, Berkeley and his Bachelor of Science degree in engineering from the United States Military Academy at West Point, New York.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle@ndapartners.com

Read the full story at https://www.prweb.com/releases/senior_regulatory_affairs_and_program_management_executive_robert_peterson_rac_joins_nda_partners/prweb16709938.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Tech Solutions Ready to Protect Nation’s Seniors; Zanthion Urges Nursing Facilities to Adapt
2. IBM and Avamere to Bring Cognitive Eldercare Research to Senior Living and Skilled Nursing Facilities
3. Zimmer Biomet Prices Offering of Euro-Denominated Senior Notes
4. Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference
5. Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer
6. EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables
7. Genes may thwart seniors exercise gains
8. CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago
9. In'Tech Expands Regulatory Affairs Initiative Globally to Support Its Customers Worldwide
10. VISTAAR Announces Addition of “ADVISORY Playbooks” to it’s Regulatory & Clinical Intelligence Platform
11. Regulatory Strategies for the Analytical Development of New Biological Entities and Biosimilars, New Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...
(Date:11/5/2019)... ... 2019 , ... Dr. Lauren Kopp celebrates one year ... WA, including porcelain veneers , smile makeovers, dental implants, and the Bioclear ... Dr. Kopp is passionate about serving her Seattle community with empathy and precision ...
(Date:10/30/2019)... ... October 30, 2019 , ... PathSensors, ... in Nashville, TN from Tuesday, November 5, 2019, to Thursday, November 7, 2019. ... biological, radiological, nuclear) and IED (explosive) threats. Delegates and experts from over 30 ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical ... with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs ... not informed of the latest data, potentially leading to patient risk. , By ...
(Date:10/30/2019)... CITY, S.D. (PRWEB) , ... October 30, 2019 , ... ... team of researchers and students at South Dakota School of Mines & Technology ... cancer cells while leaving healthy cells alive. , If successful, the technique would ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality ... Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) ... Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical executives, ...
(Date:10/22/2019)... ANGELES (PRWEB) , ... October 22, 2019 , ... nQ ... Graziadio Business School’s 2019 Most Fundable Companies List which was announced at a showcase ... than $10 million in annual revenue, strong business plans, and impressive near-term growth projections ...
Breaking Biology Technology: